EN
HI
Parmax Pharma Share price
PARMAX
42
1.53 (3.78%)Last updated on 11 Jul, 2025 | 15:27 IST
BUYSELL
Today's High
43.00
Today's Low
39.00
52 Week Low
31.50
52 Week High
55.02
The current prices are delayed, login to your account for live prices
LoginParmax Pharma Chart
Parmax Pharma Share Key Metrics
Volume
3220.00
Market Cap
15.14 CR
LTQ@LTP
2134@42.00
ATP
41.99
Var Margin
34.26 %
Circuit Range
32.38-48.56
Delivery %
0 %
Value
1.35 L
ASM/GSM
No
Market Lot
1
About Parmax Pharma
NSE : 0
BSE : 540359
ISIN : INE240T01014
Parmax Pharma Limited was incorporated as a public limitedcompany on 02-11-1994 and the company received theCertificate of commencement of business from the Registrarof Companies Gujarat on 10-3-95. The Company is planningto set up a bulk drug plant to manufacture Amoxycillin trihydrade ampicillin tri hydrade Cephalexin mono hydrateand Nalidixic acid at Hadamtala Gondal. Dist Rajkot.
Parmax Pharma Management
| Name | Position |
|---|---|
| Dr. Umang Alkesh Gosalia | Managing Director |
| Ms. Ami R Shah | Independent Director |
| Mr. Nikhil S Uchat | Independent Director |
Parmax Pharma Similar Stocks
Link Pharma Chem Ltd.
34.01
-2.61 (7.13%)
Sharma East India Hospitals & Medical Research Ltd.
79.74
1.78 (2.28%)
Clinitech Laboratory Ltd.
NaN
-33.80 (3380.00%)
Norris Medicines Ltd.
17.95
0.25 (1.41%)
Soni Medicare Ltd.
54.71
-1.11 (1.99%)
Colinz Laboratories Ltd.
40.19
0.78 (1.98%)
Broach Lifecare Hospital Ltd.
NaN
-22.00 (2200.00%)
Gian Life Care Ltd.
14.95
-0.05 (0.33%)
Unjha Formulations Ltd.
23.64
0.59 (2.56%)
Parmax Pharma FAQs
The Buying Price of Parmax Pharma share is 42 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Parmax Pharma share log in to your Choice trading account, or open a Choice Demat account, then add funds, search the company name, select your order type, and place your trade.
The Price-to-earnings (P/E) ratio of Parmax Pharma shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Parmax Pharma shares is 0. Useful to assess the stock's value relative to its book value.
To assess Parmax Pharma’s valuation compare Sector P/E, P/B which are 32.53 & 4.05 with sector averages, along with growth rates and financial metrics.
The Market Cap of Parmax Pharma is 15.14 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Parmax Pharma share price is 55.02 & 31.50. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.